FDA Recall: Cetirizine 5 mg Tablets With Possible Ranitidine Cross-Contamination

Quick answer (30–60 seconds)

What happened: The FDA posted a lot-specific recall of certain cetirizine 5 mg tablets because of potential cross-contamination with ranitidine during manufacturing.
Why it matters: The main concern is for people with ranitidine hypersensitivity, including risk of anaphylaxis (a life-threatening allergic reaction).
First step: Check your bottle’s NDC and lot number and compare them to the FDA’s recalled identifiers.

What the FDA recall says

The FDA recall alert (posted July 20, 2026) describes a voluntary nationwide recall of cetirizine hydrochloride tablets USP 5 mg distributed by Unique Pharmaceutical Laboratories (distributed under Rising Pharma Holdings Inc.).

The stated reason is potential cross-contamination with ranitidine. The FDA notes that the issue could pose a reasonable probability of serious hypersensitivity reactions and anaphylaxis for consumers with a hypersensitivity to ranitidine.

How to tell if your bottle is affected (check identifiers)

Look on your label for the NDC and the lot number (often near the label/bottle printing) and compare them to the FDA-listed recalled identifiers.

NDC: 16571-401-10
Product: Cetirizine Hydrochloride Tablets USP 5 mg (HDPE bottle, pack of 100)
Recalled lot numbers: GY825029, GY825030, GY825031, GY825032
Expiration date shown: 10/2028

If your bottle matches these identifiers, follow the recall next steps below.

Who may be at higher risk

The FDA’s risk statement is focused on people who have hypersensitivity to ranitidine.

Practical question to ask yourself or your caregiver: Have you ever been told you’re allergic to ranitidine or had a serious reaction to it? If you’re unsure, your pharmacist or clinician can help you interpret your allergy history.

Symptoms that suggest anaphylaxis (get emergency care)

Anaphylaxis is a life-threatening allergic reaction. If you notice a combination of severe symptoms affecting different parts of the body—especially breathing or circulation—treat it as an emergency.

Call 911 (or your local emergency number) right away if you or someone else has signs such as:

Trouble breathing, wheezing, or shortness of breath
Swelling of the face, lips, tongue, or throat (or trouble swallowing)
Widespread hives or skin flushing, especially with other symptoms
Vomiting or severe stomach pain
Dizziness, fainting, or feeling like you might pass out

If an epinephrine auto-injector was prescribed for a prior severe allergy, use it as directed and seek emergency care.

What to do right now

If your bottle matches the FDA identifiers: Do not use the recalled tablets. Contact your pharmacist or clinician to discuss safe next steps.
If you develop severe allergic symptoms: seek emergency care immediately. Do not wait for a reaction to “work itself out.”
If you feel okay: you should still check your NDC/lot and follow the recall guidance, since this recall is designed to prevent potentially harmful exposures.

Background: cetirizine and emergency allergy care

Cetirizine is an antihistamine commonly used for allergy symptoms. Like any medication, it can be associated with serious allergic reactions in certain situations.

MedlinePlus and major allergy guidance emphasize that epinephrine is the key emergency treatment for anaphylaxis, and that antihistamines are not a substitute for emergency epinephrine when anaphylaxis is suspected.

What you can’t know at home (uncertainty)

This recall is lot-specific, and what matters for day-to-day decision-making is whether your tablets match the FDA-listed NDC/lot/expiration identifiers.

You can’t determine the presence or severity of any cross-contamination level from the bottle alone.
You can’t predict whether a person taking a given lot will develop symptoms—especially if they have not previously had a known reaction to ranitidine.
The FDA’s warning is about potential risk; it is not a guarantee that every person who used an affected lot will have a reaction.

If you have questions about your allergy history or what to take instead, a clinician or pharmacist is the safest place to get guidance.

Key sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.